Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes
European Heart Journal Open · 01.07.2026 · 6 (4)
DOI: 10.1093/ehjopen/oeag118 ↗Kurz gefasst
Editorial in der Zeitschrift European Heart Journal Open, online erschienen am 28.07.2026. Verfasst von Carl J Lavie und 1 weiteren Autor:innen. Beteiligte Einrichtung: John Ochsner Heart and Vascular Institute, Ochsner Clinical School-University of Queensland School of Medicine, New Orleans, LA 70112, USA. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This editorial refers to ‘Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardio-vascular and non-cardiovascular outcomes in patients at high/very-high cardiovascular risk without heart failure: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials’, by S. Masi
Autor:innen und Institutionen
- John Ochsner Heart and Vascular Institute, Ochsner Clinical School-University of Queensland School of Medicine, New Orleans, LA 70112, USA.
- Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Rzgowska 281/289, 93-338 Lodz, Poland.
- Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
ORCID-Profile: Carl J Lavie, Maciej Banach
Zitieren
APA
Lavie, C. J., & Banach, M. (2026). Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes. European Heart Journal Open, 6(4). https://doi.org/10.1093/ehjopen/oeag118
Vancouver
Lavie CJ, Banach M. Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes. European Heart Journal Open. 2026;6(4). doi:10.1093/ehjopen/oeag118
BibTeX
@article{Lavie2026,
author = {Lavie, Carl J and Banach, Maciej},
title = {Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes},
journal = {European Heart Journal Open},
year = {2026},
volume = {6},
number = {4},
doi = {10.1093/ehjopen/oeag118}
}
EUVIMED